Sanofi-Aventis Canada Inc. v. Eli Lilly Canada Inc.

We successfully represented Eli Lilly in a patent proceeding relating to Eli Lilly’s diabetes medicine BASAGLAR.

After filing a motion to dismiss the proceeding, Sanofi discontinued the case.